Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 69
Filter
Add more filters

Country/Region as subject
Publication year range
1.
Lett Appl Microbiol ; 63(1): 38-44, 2016 Jul.
Article in English | MEDLINE | ID: mdl-27163966

ABSTRACT

UNLABELLED: 2,5-Bis(hydroxymethyl)furan monoacetate (BHMF-OAc) compound was isolated from the culture filtrate secreted by Streptomyces sp. CEN26, an endophytic actinomycete found in the root nodes of Centella asiatica (L.) Urban. The compound was purified using various chromatographic techniques and bioassay-guided fractionation. The compound was then identified through a structural characterization using (1) H, (13) C-NMR and MS analysis. After the purification and identification process, a series of experiments were conducted in order to test whether the compound affected conidial germination of Alternaria brassicicola. Findings show that the compound inhibited and deformed the conidial germination of A. brassicicola. Its minimal inhibitory concentrations of MIC90 and MIC50 were found to be 100 and 25 ppm respectively. Further experimentation show that the aforementioned concentrations of MIC90 and MIC50 completely suppressed the appressorium formation of the fungal pathogen. Therefore, the BHMF-OAc compound does have antifungal properties that help protect plants from infection by A. brassicicola. SIGNIFICANCE AND IMPACT OF THE STUDY: Endophytic Streptomyces sp. CEN26 produces 2,5-bis(hydroxymethyl)furan monoacetate (BHMF-OAc), which is a compound that inhibits the infection process of Alternaria brassicicola in cabbage. Such an antifungal property would allow for the use of the BHMF-OAc as an alternative to chemical fungicides.


Subject(s)
Alternaria/drug effects , Antifungal Agents/pharmacology , Brassica/microbiology , Fungicides, Industrial/pharmacology , Furans/pharmacology , Plant Diseases/microbiology , Streptomyces/metabolism , Antifungal Agents/isolation & purification , Centella/microbiology , Fungicides, Industrial/isolation & purification , Furans/isolation & purification , Microbial Sensitivity Tests , Spores, Fungal/drug effects
2.
J Fish Dis ; 37(8): 719-28, 2014 Aug.
Article in English | MEDLINE | ID: mdl-24033791

ABSTRACT

A selective and differential medium termed 'LG agar' was developed for the isolation and presumptive identification of Lactococcus garvieae that results in black colonies with red halos. In this study, all 14 strains of L. garvieae and only 9 of the 148 strains representing 38 other species were able to grow on the LG agar. The nine viable strains on LG agar plates (including Enterococcus faecalis, Enterococcus faecium, Lactococcus lactis, Vibrio fluvialis, Vibrio furnissii, Vibrio mimicus and Vibrio salmonicida) were further differentiated from L. garvieae by various colours or colony features. Colonies isolated from the mixing culture and the infected giant sea perch using LG agar plates were all positively identified as L. garvieae by conventional tests and 16S rDNA sequencing. Furthermore, LG agar discriminated capsulated strains of L. garvieae, which were believed to be correlated with pathogens of fish and shellfish, from non-capsulated ones by colony appearances. The specificity and differentiating ability of LG agar suggest that this medium displays considerable potential for primary isolation and presumptive identification of L. garvieae from pathological and environmental samples.


Subject(s)
Bacterial Capsules/physiology , Bacterial Typing Techniques/methods , Culture Media/chemistry , Lactococcus/physiology , Animals , Lactococcus/classification , Species Specificity
3.
Strahlenther Onkol ; 189(8): 675-83, 2013 Aug.
Article in English | MEDLINE | ID: mdl-23780339

ABSTRACT

BACKGROUND AND PURPOSE: Betel nut chewing is associated with oral cavity cancer in Taiwan. OC3 is an oral carcinoma cell line that was established from cells collected from a long-term betel nut chewer who does not smoke. After we found that microRNA-17-5p (miR-17-5p) is induced in OC3 cells, we used this cell line to examine the biological role(s) of this microRNA in response to exposure to ionizing radiation. MATERIALS AND METHODS: A combined SYBR green-based real-time PCR and oligonucleotide ligation assay was used to examine the expression of the miR-17 polycistron in irradiated OC3 cells. The roles of miR-17-5p and p21 were evaluated with specific antisense oligonucleotides (ODN) that were designed and used to inhibit their expression. Expression of the p21 protein was evaluated by Western blotting. The clonogenic assay and annexin V staining were used to evaluate cell survival and apoptosis, respectively. Cells in which miR-17-5p was stably knocked down were used to create ectopic xenografts to evaluate in vivo the role of miR-17-5p. RESULTS: A radiation dose of 5 Gy significantly increased miR-17-5p expression in irradiated OC3 cells. Inhibition of miR-17-5p expression enhanced the radiosensitivity of the OC3 cells. We found that miR-17-5p downregulates radiation-induced p21 expression in OC3 cells and, by using a tumor xenograft model, it was found that p21 plays a critical role in increasing the radiosensitivity of OC3 cells in vitro and in vivo. CONCLUSION: miR-17-5p is induced in irradiated OC3 cells and it downregulates p21 protein expression, contributing to the radioresistance of OC3 cells.


Subject(s)
Areca/poisoning , Carcinoma, Squamous Cell/genetics , Cyclin-Dependent Kinase Inhibitor p21/genetics , Gene Expression Regulation, Neoplastic/genetics , MicroRNAs/genetics , Mouth Neoplasms/genetics , RNA Processing, Post-Transcriptional/genetics , Administration, Oral , Cell Line, Tumor , Down-Regulation/genetics , Down-Regulation/radiation effects , Gene Expression Regulation, Neoplastic/radiation effects , Humans , RNA Processing, Post-Transcriptional/radiation effects , Radiation Tolerance/genetics
4.
Ann Oncol ; 23(1): 245-250, 2012 Jan.
Article in English | MEDLINE | ID: mdl-21515664

ABSTRACT

BACKGROUND: The size of the breast stem-cell pool could underlie the intrauterine roots of breast cancer. We studied whether breast stem cells exist in umbilical cord blood and if they correlate with hematopoietic stem-cell measurements that have been positively associated with perinatal risk factors for breast cancer. SUBJECTS AND METHODS: We isolated mononuclear cells from umbilical cord blood of 170 singleton full-term pregnancies and determined, by reverse transcription polymerase chain reaction, the presence of genes of putative breast epithelial stem-cell/progenitor markers [including epithelial cell adhesion molecule (EpCAM), CD49f (α6-integrin), CD117 (c-kit receptor), CD24, and CD29 (ß1-integrin)]. By immunocytochemistry, we colocalized protein expressions of EpCAM+CD49f+, CD49f+CD24+, and CD24+CD29+. We correlated concentrations of putative breast stem-cell/progenitor subpopulations, quantified by flow cytometry, with concentrations of hematopoietic stem cells. RESULTS: Mammary stem-cell phenotypes were identified in umbilical cord blood. The measured EpCAM+ subpopulation was positively correlated with concentrations of CD34+ and CD34+CD38- hematopoietic stem cells (both P=0.006). Additionally, EpCAM+CD49f+ and CD49f+CD24+ subpopulations were positively correlated to the CD34+ cells (P=0.03 and 0.008, respectively). CONCLUSION: The positive association between measurable breast and hematopoietic stem cells in human umbilical cord blood suggests plausible mechanisms for a prenatal influence on breast cancer risk.


Subject(s)
Biomarkers, Tumor/analysis , Breast/cytology , Fetal Blood/cytology , Stem Cells/cytology , Antigens, Neoplasm/analysis , Antigens, Neoplasm/biosynthesis , Breast/metabolism , Breast Neoplasms/metabolism , CD24 Antigen/analysis , CD24 Antigen/biosynthesis , Cell Adhesion Molecules/analysis , Cell Adhesion Molecules/biosynthesis , Cell Separation , Disease Susceptibility , Epithelial Cell Adhesion Molecule , Female , Flow Cytometry , Hematopoietic Stem Cells/cytology , Humans , Immunohistochemistry , Integrin alpha6/analysis , Integrin alpha6/biosynthesis , Integrin beta1/analysis , Integrin beta1/biosynthesis , Leukocytes, Mononuclear/cytology , Microscopy, Confocal , Proto-Oncogene Proteins c-kit/analysis , Proto-Oncogene Proteins c-kit/biosynthesis , Reverse Transcriptase Polymerase Chain Reaction , Stem Cells/metabolism
5.
Osteoporos Int ; 23(5): 1571-80, 2012 May.
Article in English | MEDLINE | ID: mdl-21901480

ABSTRACT

UNLABELLED: The treatment of 300-mg/day isoflavones (aglycone equivalents) (172.5 mg genistein + 127.5 mg daidzein) for 2 years failed to prevent lumbar spine and total proximal femur bone mineral density (BMD) from declining as compared with the placebo group in a randomized, double-blind, two-arm designed study enrolling 431 postmenopausal women 45-65 years old. INTRODUCTION: This study evaluated the effects of soy isoflavones on bone metabolism in postmenopausal women. METHODS: Four hundred and thirty-one women, aged 45-65 years, orally consumed 300-mg/day isoflavones (aglycone equivalents) or a placebo for 2 years in a parallel group, randomized, double-blind, two-arm study. Each participant also ingested 600 mg of calcium and 125 IU of vitamin D(3) per day. The BMD of the lumbar spine and total proximal femur were measured using dual-energy X-ray absorptiometry at baseline and every half-year thereafter. Serum bone-specific alkaline phosphatase, urinary N-telopeptide of type 1 collagen/creatinine, and other safety assessments were examined regularly. RESULTS: Two hundred out of 217 subjects in the isoflavone group and 199 out of 214 cases in placebo group completed the treatment. Serum concentrations of isoflavone metabolites, genistein and daidzein, of the intervention group were remarkably elevated following intake of isoflavones (p < 0.001). However, differences in the mean percentage changes of BMD throughout the treatment period were not statistically significant (lumbar spine, p = 0.42; total femur, p = 0.39) between the isoflavone and placebo groups, according to the generalized estimating equation (GEE) method. A significant time trend of bone loss was observed at both sites as assessed by the GEE method following repeated measurement of BMD (p < 0.001). Differences in bone marker levels were not significant between the two treatment groups. CONCLUSION: Treatment with 300-mg/day isoflavones (aglycone equivalents) failed to prevent a decline in BMD in the lumbar spine or total femur compared with the placebo group.


Subject(s)
Bone Density/drug effects , Genistein/therapeutic use , Isoflavones/therapeutic use , Osteoporosis, Postmenopausal/drug therapy , Phytoestrogens/therapeutic use , Absorptiometry, Photon/methods , Bone Density Conservation Agents/adverse effects , Bone Density Conservation Agents/pharmacology , Bone Density Conservation Agents/therapeutic use , Double-Blind Method , Drug Administration Schedule , Drug Combinations , Female , Femur/physiopathology , Genistein/adverse effects , Genistein/pharmacology , Humans , Isoflavones/adverse effects , Isoflavones/pharmacology , Lumbar Vertebrae/physiopathology , Middle Aged , Osteoporosis, Postmenopausal/physiopathology , Phytoestrogens/adverse effects , Phytoestrogens/pharmacology , Placebos , Treatment Outcome
6.
J Fish Dis ; 34(3): 227-34, 2011 Mar.
Article in English | MEDLINE | ID: mdl-21306589

ABSTRACT

In this paper, we present a selective and differential medium, termed Vibrio alginolyticus (VAL) agar, developed for the isolation and identification of V. alginolyticus. The presence of bile salts, high salinity and high incubation temperature allows the selective growth of moderately halophilic Vibrio species. Differentiation of bacteria is achieved by identifying species capable of sucrose fermentation, made visible by the pH indicator bromocresol purple. In this study, all of the 26 strains of V. alginolyticus and only three of the 99 strains representing 30 species (including 19 Vibrio species) other than V. alginolyticus were able to grow in the VAL medium. The remaining three strains could be further differentiated from V. alginolyticus according to colour or the diameter of colonies produced on VAL agar plates. Colonies isolated from shellfish rearing water and infected shrimp through the use of VAL agar plates were all positively identified as V. alginolyticus by conventional tests and 16S rDNA sequencing. The testing of specificity and differentiation capability of VAL shows the potential of the agar as a medium for the primary isolation of V. alginolyticus from pathological and environmental samples.


Subject(s)
Bacterial Typing Techniques/methods , Culture Media , Vibrio alginolyticus/physiology , RNA, Ribosomal, 16S/genetics , Reproducibility of Results , Salinity , Sensitivity and Specificity , Shellfish/microbiology , Vibrio alginolyticus/growth & development , Vibrio alginolyticus/isolation & purification
8.
Transplant Proc ; 40(8): 2611-3, 2008 Oct.
Article in English | MEDLINE | ID: mdl-18929816

ABSTRACT

Patients receive methylprednisolone pulse therapy (MPT) when acute cardiac rejection occurs. Although the regimen is generally safe and effective, severe complications occasionally develop. From 1997 to 2007, there were 210 cardiac transplantation procedures performed at our hospital. Among these patients, there were 23 episodes of acute rejection treated with MPT, 10 mg/kg/d. Two patients in our series had cardiac arrest within 36 hours after initiating the therapy. Endomyocardial biopsy specimens showed International Society for Heart Transplantation grade 1B allograft rejection in both cases. Emergent intubation and cardiopulmonary resuscitation were performed. Venoarterial extracorporeal membrane oxygenation (ECMO) was used to rescue the patients. The cardiac function in both patients recovered gradually. Left ventricular ejection fraction increased from 16.2% to 47% in one patient and from 27% to 30% in the other patient. One patient was successfully weaned from ECMO after 2 days of support. The other patient was discharged against medical advice because of hypoxia-related brain death after 3 days. Both patients had a history of tachyarrhythmias before initiation of MPT. Although the relationship between mechanisms of cardiac arrest and MPT is uncertain, the risk of cardiac arrest cannot be overlooked when initiating MPT, especially in patients with a history of tachyarrhythmia. Meanwhile, ECMO can serve as a rescue method if cardiac arrest occurs.


Subject(s)
Extracorporeal Membrane Oxygenation , Heart Arrest/chemically induced , Heart Transplantation/adverse effects , Methylprednisolone/adverse effects , Child, Preschool , Graft Rejection , Heart Transplantation/pathology , Humans , Male , Methylprednisolone/therapeutic use , Middle Aged , Treatment Outcome , Ventricular Dysfunction, Left/diagnosis
9.
Transplant Proc ; 38(7): 2130-1, 2006 Sep.
Article in English | MEDLINE | ID: mdl-16980021

ABSTRACT

Heart transplantation (HTx) is a treatment for end-stage heart failure or a complex or inoperable congenital defect. The long-term survival and the adequate donor to recipient body weight (D/R BW) ratio remain to be determined. From March 1995 to May 2004, 14 children (6 months-16 years of age) underwent HTx due to underlying diseases of idiopathic dilated cardiomyopathy (n = 10; 71.4%), congenital heart disease (n = 3; 21.4%), and Kawasaki disease (n = 1; 7.1%). Donor-recipient body weight ratio ranged from 0.89 to 3.9. Big heart syndrome was present in one patient when D/R BW ratio was more than 3. Actuarial survival was 92.9% at 5 years after transplantation. Only the one patient who had Kawasaki disease died due to early primary graft failure. HTx is a feasible method with good long-term survival rates for end-stage heart failure or for complex or inoperable congenital defects. After careful pretransplant evaluation, a high D/R BW ratio (more than 3) is acceptable.


Subject(s)
Heart Transplantation/physiology , Body Weight , Child , Child, Preschool , Heart Diseases/classification , Heart Diseases/surgery , Heart Transplantation/statistics & numerical data , Humans , Retrospective Studies , Taiwan
11.
Cancer Res ; 61(3): 1100-6, 2001 Feb 01.
Article in English | MEDLINE | ID: mdl-11221839

ABSTRACT

Macrophages use L-arginine to synthesize nitric oxide (NO) and polyamines through the inducible NO synthase (iNOS) and arginase, respectively. The released NO contributes to the tumoricidal activity of macrophages, whereas polyamines may promote the growth of tumor cells. Both the tumoricidal and growth-promoting activities from macrophages have been reported; however, the underlying mechanisms for switching between this dual function of macrophages remain unclear. Here, we test the hypothesis that arginase participates in the switching between the cytotoxic and growth-promoting activities of macrophages toward tumor cells. To alter arginase activity in macrophages, cells (murine macrophage cell line J774A.1) were transfected with the rat liver arginase gene or treated with an arginase inhibitor, L-norvaline. The effects of macrophage arginase activity on the growth-promoting and cytotoxic activities of macrophages toward breast tumor cells (ZR-75-1) were investigated in a coculture system. The results demonstrated that overexpression of arginase in macrophages enhanced L-ornithine and putrescine production and consequently promoted tumor cell proliferation. This proliferative effect was down-regulated by the arginase inhibitor L-norvaline. Furthermore, increases in arginase activity also attenuated NO production by the lipopolysaccharide-activated macrophages and thus reduced the cytotoxic effect on cocultured tumor cells. Inhibiting arginase activity by L-norvaline effectively reversed the suppression of NO-mediated tumor cytotoxicity. Together, these results suggest that arginase induction in macrophages can enhance tumor cell growth by providing them with polyamines and suppress tumor cytotoxicity by reducing NO production. It appears that L-arginine metabolism through the arginase and iNOS pathways in macrophages can have very different influences on the growth of nearby tumor cells depending on which pathway is prevailing.


Subject(s)
Adenocarcinoma/pathology , Arginase/physiology , Breast Neoplasms/pathology , Macrophages/enzymology , Nitric Oxide/physiology , Valine/analogs & derivatives , Adenocarcinoma/metabolism , Animals , Arginase/genetics , Arginase/metabolism , Arginine/metabolism , Biogenic Polyamines/metabolism , Breast Neoplasms/metabolism , Cell Division/physiology , Coculture Techniques , Cytotoxicity, Immunologic/physiology , Humans , Macrophage Activation/physiology , Macrophages/immunology , Macrophages/physiology , Mice , Nitric Oxide/biosynthesis , Nitric Oxide/immunology , Ornithine/metabolism , Rats , Transfection , Valine/pharmacology
12.
Clin Microbiol Infect ; 22(4): 382.e1-382.e11, 2016 Apr.
Article in English | MEDLINE | ID: mdl-26794030

ABSTRACT

Postprocedural infections by Mycobacterium abscessus complex are increasing worldwide, and the source and route of transmission are infrequently identified. Here the extension of a previous clustering of paediatric patients with surgical site infections due to a single strain of the subspecies M. massiliense is reported. The investigation was conducted at a 2200-bed teaching hospital in Taiwan and included microbial surveillance of the environment (water, air, equipment and supplies) and a case-control study. We performed molecular identification and typing of the isolates by a trilocus sequencing scheme, confirmed by multilocus sequencing typing and pulsed-field gel electrophoresis. We investigated 40 patients who developed postprocedure soft tissue or bloodstream infections by M. massiliense (TPE101) during a 3-year period. Thirty-eight patients were identified at hospital A, and one newborn and her mother were identified at hospital B (185 km from hospital A). A case-control study identified the association of invasive procedures (adjusted odds ratio, 9.13) and ultrasonography (adjusted odds ratio, 2.97) (both p <0.05) with acquiring the outbreak strain. Isolates from the cases and unopened bottles of ultrasound transmission gel were all of strain ST48 and indistinguishable or closely related by pulsed-field gel electrophoresis. After replacement of contaminated gel, no new cases were detected during 18 months' follow-up. This investigation identified the use of contaminated gel as the common source causing an outbreak on a larger scale than had been recognized. Our findings halted production by the manufacturer and prompted revision of hospital guidelines.


Subject(s)
Disease Outbreaks , Drug Contamination , Mycobacterium Infections, Nontuberculous/epidemiology , Nontuberculous Mycobacteria/isolation & purification , Surgical Wound Infection/epidemiology , Ultrasonography/adverse effects , Adolescent , Adult , Aged , Aged, 80 and over , Case-Control Studies , Electrophoresis, Gel, Pulsed-Field , Female , Genotype , Hospitals, Teaching , Humans , Infant , Infant, Newborn , Male , Middle Aged , Multilocus Sequence Typing , Mycobacterium Infections, Nontuberculous/microbiology , Nontuberculous Mycobacteria/classification , Nontuberculous Mycobacteria/genetics , Retrospective Studies , Surgical Wound Infection/microbiology , Taiwan/epidemiology
13.
J Am Coll Cardiol ; 37(3): 940-7, 2001 Mar 01.
Article in English | MEDLINE | ID: mdl-11693774

ABSTRACT

OBJECTIVES: The results of percutaneous balloon angioplasty for obstructed modified Blalock-Taussig (BT) or central shunts and pulmonary artery (PA) stenoses were studied to assess its role as an alternative to second shunt and surgical PA angioplasty. BACKGROUND: Obstruction of a modified shunt and PA stenosis related to the shunt or ductus are not infrequent. A second shunt with or without PA angioplastv is required if the PA size, morphology or age of the patient is suboptimal for definitive surgery. METHODS: From June 1994 to May 1999, balloon angioplasty for obstructed systemic-to-PA shunts was performed in 46 patients, with ages ranging from 1 month to 7.4 years (2.2 +/- 1.9 years). Among the 46 patients, 32 had modified BT shunts, 5 had bilateral shunts, 7 had modified central shunts, and 2 had both modified BT and central shunts. Stenoses were seen in 27 main branch PAs, and interruption was present in three. A concurrent balloon angioplasty was attempted in 28 main branch PAs, but it was performed in only 25 vessels. RESULTS: Balloon dilation for obstructed modified shunts was considered to be effective in 42 patients (91%), while angioplasty for PA stenosis was effective in 14 vessels and not effective in 11 vessels. After balloon dilation angioplastv, oxygen saturation in the aorta increased from 74.4 +/- 4.3% to 80.8 +/- 3.6% (p < 0.01) in these 46 patients. One patient died of pneumonia. Eight patients required an additional modified BT shunt soon after the procedure because of severe stenosis or interruption at main branch PA. After a mean follow-up period of 11.6 +/- 5.4 months, 29 patients underwent a repeated imaging study to evaluate the morphology and size of the PAs. Of these 29 patients, 26 underwent open-heart surgery, with two mortalities. CONCLUSIONS: When a second shunt is under consideration because of obstruction of the modified shunt, balloon angioplasty is a possible alternative procedure. Pulmonary artery stenosis, if present, can be simultaneously dilated.


Subject(s)
Angioplasty, Balloon , Blood Vessel Prosthesis Implantation , Graft Occlusion, Vascular/therapy , Pulmonary Artery/pathology , Child , Child, Preschool , Constriction, Pathologic , Female , Humans , Infant , Infant, Newborn , Male , Radiography , Subclavian Artery/diagnostic imaging
14.
Am J Cardiol ; 84(9): 1055-60, 1999 Nov 01.
Article in English | MEDLINE | ID: mdl-10569663

ABSTRACT

The results of transcatheter valvotomy in pulmonary atresia with intact ventricular septum (PA-IVS) patients are presented with an attempt to identify the predictive factors for pulmonary valvotomy alone as definitive treatment. Between June 1995 and December 1997, 14 PA-IVS neonates with tripartite right ventricle underwent an attempted pulmonary valvotomy. For perforation of the pulmonary valve, a guidewire was used in 4, and a radiofrequency guidewire in 10 patients. Two outcome groups were identified. Group I included those in whom transcatheter treatment achieved a definitive success; group II patients required surgery despite an initial successful valvotomy. The attempt failed in 3 patients, 1 of whom had pericardial effusion. Perforation of the pulmonary valve was achieved in 11 patients: 2 with a guidewire and 9 with a radiofrequency guidewire. A subsequent balloon valvuloplasty was performed in these 11 patients. After valvuloplasty, mean right ventricular pressure decreased from 124 +/- 24 to 60 +/- 15 mm Hg (p <0.01). One died of heart failure and infection 10 days later, despite successful weaning from prostaglandin E1. Group I patients (n = 6) were treated with transcatheter valvotomy alone. Group II patients (n = 4) required right ventricular outflow patch. Significant differences between the 2 groups (group I vs II) were identified in tricuspid valve Z value (0.52 +/- 0.37 vs -1.25 +/- 0.48, p <0.05), pulmonary valve Z value (-3.47 +/- 0.59 vs -5.43 +/- 0.94, p <0.05), and ratio of right-to-left ventricular area on the apical 4-chamber view (0.73 +/- 0.06 vs 0.49 +/- 0.03, p <0.05). There were no significant differences in hemodynamic characteristics between the 2 groups. After a follow-up period ranging from 7 to 35 months (mean 18 +/- 10.3), the most recent echocardiograms in the 10 patients showed a mean pressure gradient across the pulmonary valve of 17 +/- 15 mm Hg. All 10 patients had an oxygen saturation of >92%. Transcatheter valvotomy using a radiofrequency guidewire is a safe and effective treatment in selected patients with PA-IVS. Transcatheter valvotomy can be a definitive treatment in PA-IVS patients with a tricuspid valve Z value > or = -0.1, pulmonary valve Z value > or = -4.1 and ratio of right-to-left ventricular area > or = 0.65.


Subject(s)
Catheterization/instrumentation , Heart Septum , Pulmonary Atresia/therapy , Child, Preschool , Echocardiography , Equipment Design , Female , Follow-Up Studies , Heart Septum/diagnostic imaging , Hemodynamics/physiology , Humans , Infant , Infant, Newborn , Male , Pulmonary Atresia/diagnostic imaging , Pulmonary Atresia/mortality , Survival Rate , Treatment Outcome
15.
Am J Cardiol ; 77(10): 839-42, 1996 Apr 15.
Article in English | MEDLINE | ID: mdl-8623736

ABSTRACT

Double-chambered right ventricle (DCRV) is commonly associated with ventricular septal defect (VSD). In this study, an assessment was made of the relevance of a malalignment-type VSD to hemodynamic and morphologic features in DCRV. During an 8.5-year period, 53 patients with DCRV were enrolled after study with echocardiography, catheterization, and angiography. Patients were divided into 2 groups: group I included 40 patients, aged 3.7 +/- 3.2 years, with a malalignment-type VSD; group II consisted of 13 patients, aged 8.6 +/- 2.7 years, without a malalignment-type VSD. History of congestive heart failure in infancy was present in 21 group I and 2 group II patients (53% vs 15%, respectively, p <0.05). The mean pulmonary-to-systemic flow ratio was significantly higher in group I than in group II (1.89 +/- 0.74 vs 1.14 +/- 0.21, respectively, p <0.05). The mean pressure gradient across the right ventricular outflow tract was lower in group I than in group II (41 +/- 16 vs, 73 +/- 33 mm Hg, respectively, p <0.05). Among 42 patients who had a series of echocardiograms recorded, progression of pressure gradient was evident in 35: 28 in group I and 7 in group II. A subaortic ridge was present exclusively in 29 group I patients (73%). Prolapse of the aortic valve was present in 26 (49%): 20 group I (50%) and 6 group II (46%) patients. Aneurysm formation of the septal defect was found in 17 (43%) and 7 (54%) group I and II patients, respectively. It can be concluded that a history of congestive heart failure was more common in DCRV patients with a malalignment-type VSD. Malalignment-type VSD is significantly associated with a larger pulmonary-to-systemic flow ratio and subaortic ridge.


Subject(s)
Heart Septal Defects, Ventricular/physiopathology , Heart Ventricles/abnormalities , Adolescent , Child , Child, Preschool , Echocardiography , Female , Heart Septal Defects, Ventricular/complications , Heart Septal Defects, Ventricular/diagnostic imaging , Heart Septal Defects, Ventricular/pathology , Heart Ventricles/pathology , Hemodynamics , Humans , Male
16.
Am J Cardiol ; 72(7): 596-601, 1993 Sep 01.
Article in English | MEDLINE | ID: mdl-8362777

ABSTRACT

Defects on the membranous ventricular septum (perimembranous ventricular septal defect [VSD]) may spontaneously close or diminish in size by "aneurysmal transformation" (i.e., adherence of the tricuspid valve or adjacent tissue onto the VSD). It was recently shown that the appearance of aneurysmal transformation may be associated with subaortic ridges, as well as left ventricular (LV)-to-right atrial (RA) shunts. In all, 877 consecutive patients with isolated perimembranous VSD were retrospectively studied. Results of actuarial analysis showed that patients with a perimembranous VSD had a 98% probability of aneurysmal transformation by the age of 240 months. Of these patients, the expected probabilities of developing LV-RA shunt, spontaneous closure and subaortic ridge were 45, 35 and 6%, respectively. Patients with LV-RA shunts had higher probabilities of developing infective endocarditis (p = 0.002) and persistent left-to-right shunts (p < 0.001). The presence of a subaortic ridge may be accompanied by LV outflow tract obstruction (10 of 25 patients), infundibular pulmonary stenosis (n = 3), or aortic valve deformity or aortic regurgitation (n = 5), and none of those with a subaortic ridge closed spontaneously. It was confirmed that a substantial proportion of aneurysmal transformation of isolated perimembranous VSD is associated with LV-RA shunts and subaortic ridges.


Subject(s)
Heart Aneurysm/etiology , Heart Septal Defects, Ventricular/complications , Age Factors , Child , Child, Preschool , Echocardiography , Follow-Up Studies , Heart Aneurysm/diagnostic imaging , Heart Aneurysm/epidemiology , Heart Septal Defects, Ventricular/diagnostic imaging , Heart Septal Defects, Ventricular/epidemiology , Humans , Infant , Infant, Newborn , Life Tables , Probability , Remission, Spontaneous , Retrospective Studies
17.
Am J Cardiol ; 81(2): 188-94, 1998 Jan 15.
Article in English | MEDLINE | ID: mdl-9591903

ABSTRACT

Children with heterotaxy syndrome frequently have complex cardiac and noncardiac malformations requiring detailed diagnostic evaluation for management planning. Direct delineation of these structures by electron beam computed tomography (EBCT) is validated as a means of diagnosis. From July 1995 to March 1997, 32 patients (16 girls, 16 boys) with clinically impressed heterotaxy syndrome were enrolled in this study. After evaluation by echocardiography, EBCT studies were performed. Interpretation of cardiac anomalies was performed by sequential analysis based on these cross-sectional images. The diagnoses were subsequently confirmed by angiocardiography and surgical findings. Twenty-eight patients had bilateral trifurcated bronchi, and most of these (24 of 28) did not have a spleen. Four patients had bilateral bifurcated bronchi, 2 patients had polysplenia, and the other 2 patients had a lobulated single spleen. We found that laterality could be identified by EBCT in all patients. Comparison of diagnostic yield between echocardiography, catheterization, and EBCT showed that EBCT is superior to echocardiography and catheterization in demonstration of pulmonary venous anatomy and presence of a very small rudimentary ventricle. In addition, associated visceral, bronchopulmonary, mediastinal, and intracardiac anomalies could all be clearly delineated by EBCT at the same time. Thus, EBCT is a promising complementary modality for an overall understanding of heterotaxy syndrome.


Subject(s)
Abnormalities, Multiple/diagnostic imaging , Heart Defects, Congenital/diagnostic imaging , Tomography, X-Ray Computed , Adolescent , Bronchi/abnormalities , Cardiac Catheterization , Child , Child, Preschool , Cineangiography , Echocardiography , Female , Humans , Infant , Infant, Newborn , Male , Reproducibility of Results , Retrospective Studies , Spleen/abnormalities , Syndrome
18.
J Thorac Cardiovasc Surg ; 94(6): 897-903, 1987 Dec.
Article in English | MEDLINE | ID: mdl-3682859

ABSTRACT

An integral part of the heart with an atrioventricular septal defect and a Rastelli type A valve configuration is left ventricular outflow tract obstruction. Current surgical techniques do not cater to this particular anatomic facet, and left ventricular outflow tract obstruction has been reported as a postoperative problem. The present study has focused on the surgical anatomy of the mode of attachment of the left superior atrioventricular valve and its relationship to the left ventricular outflow tract. It appeared that the anchoring of the superior leaflet was a major factor in limiting the excursions of the superior leaflet, contributing also to the tightness of the subaortic left ventricular outflow channel. On that basis a surgical repair is proposed in which the greater part of the tightly bound superior leaflet is detached from the septal crest, so that the left ventricular outflow tract is widened.


Subject(s)
Endocardial Cushion Defects/surgery , Heart Septal Defects/surgery , Ventricular Outflow Obstruction/surgery , Chordae Tendineae/pathology , Endocardial Cushion Defects/complications , Endocardial Cushion Defects/pathology , Heart Septum/pathology , Humans , Ventricular Outflow Obstruction/complications , Ventricular Outflow Obstruction/pathology
19.
Ann Thorac Surg ; 61(2): 651-6, 1996 Feb.
Article in English | MEDLINE | ID: mdl-8572782

ABSTRACT

BACKGROUND: Conventional and modified ultrafiltration was used in pediatric cardiac operations to reduce volume overload and total body water. The purpose of this study was to compare the efficacy of these techniques in removing inflammatory mediators during cardiopulmonary bypass. METHODS: Fifty pediatric patients undergoing cardiac operations were randomized into a modified or conventional ultrafiltration group. Blood samples were obtained before and after ultrafiltration to assess the plasma concentrations of leukocyte elastase, tumor necrosis factor-alpha, interleukin-6, and interleukin-8. RESULTS: Except for plasma concentrations of tumor necrosis factor-alpha in the modified ultrafiltration group, the plasma concentrations of all the mediators measured increased after ultrafiltration in both groups of patients. The volume of ultrafiltrate and the total amounts of tumor necrosis factor-alpha and interleukin-6 removed by ultrafiltration were significantly greater in the modified group. The concentrations of mediators in the ultrafiltrate and the ratio of ultrafiltrate to plasma concentrations of the mediators did not differ between the groups. Ultrafiltration was more efficient in removing tumor necrosis factor-alpha than the other mediators. CONCLUSIONS: The efficacy in removing the inflammatory mediators generated during cardiopulmonary bypass did not differ between modified and conventional ultrafiltration.


Subject(s)
Cardiac Surgical Procedures/methods , Cardiopulmonary Bypass/adverse effects , Inflammation Mediators/blood , Ultrafiltration/methods , Analysis of Variance , Child, Preschool , Female , Hematocrit , Hemoglobins/analysis , Humans , Infant , Interleukin-6/blood , Interleukin-8/blood , Leukocyte Elastase/blood , Male , Pancreatic Elastase/blood , Prospective Studies , Tumor Necrosis Factor-alpha/analysis
20.
Int J Cardiol ; 45(1): 80-2, 1994 Jun 01.
Article in English | MEDLINE | ID: mdl-7995666

ABSTRACT

A case of 'absent' left pulmonary vein with ventricular septal defect was diagnosed based on echocardiography, magnetic resonance imaging and cardiac catheterization at newborn stage. Pulmonary arterial banding was performed at the age of 1 month to ameliorate the pulmonary flow. At a cardiac catheterization 1 year later, the left pulmonary veins were visualized with moderate stenosis at their entrance into the left atrium. The patient has been stable after surgical repair of the ventricular septal defect and dilation of the pulmonary venous stenosis.


Subject(s)
Cardiac Catheterization , Heart Septal Defects, Ventricular/therapy , Pulmonary Artery/surgery , Pulmonary Veno-Occlusive Disease/therapy , Catheterization , Combined Modality Therapy , Echocardiography , Heart Septal Defects, Ventricular/complications , Heart Septal Defects, Ventricular/diagnosis , Humans , Infant, Newborn , Ligation , Magnetic Resonance Imaging , Male , Pulmonary Artery/pathology , Pulmonary Circulation , Pulmonary Veno-Occlusive Disease/complications , Pulmonary Veno-Occlusive Disease/diagnosis , Pulmonary Veno-Occlusive Disease/physiopathology
SELECTION OF CITATIONS
SEARCH DETAIL